AGITG Trial news: The AGITG currently has seventeen studies open to recruitment and nine studies in follow up.
The table below details the AGITG trials that are currently accruing patients.
| Recruited | Target | Date of First Site Open (ANZ) | Number of Sites Open | End of Recruitment | |
| DYNAMIC-III (Colon cancer) | 748 | 1000 | 09 October 2017 | 43 | April 2022 |
| DYNAMIC-Pancreas (Pancreatic cancer) | 108 | 438 | 01 March 2019 | 26 | August 2023 |
| GENESCREEN 5-FU (Pan Tumour) | 63 | 100 | 1 February 2021 | 3 | April 2025 |
| INTEGRATE IIb (Gastro-oesophageal cancer) | 130 | 450 | 28 April 2021 | 24 | April 2023 |
| LICPIC (Colorectal cancer) | 86 | 100 | 11 September 2018 | 2 | September 2024 |
| MASTERPLAN (Pancreatic cancer) | 29 | 120 | 01 October 2019 | 11 | October 2023 |
| OXTOX (Colorectal cancer) | 12 | 100 | 18 December 2020 | 7 | June 2022 |
| PALEO (Oesophageal cancer) | 2 | 54 | 3 December 2021 | 1 | May 2023 |
| RANDOMS (Pancreatic cancer) | 7 | 60 | 14 December 2020 | 3 | February 2024 |
| RENO (Rectal cancer) | 53 | 125 | 21 January 2019 | 8 | January 2024 |
| RESOLUTE (Colorectal Cancer) | 0 | 75 | 14 December 2021 | 1 | June 2023 |
| RoLaCaRT-1 (Colorectal Cancer) | 14 | 50 | 06 August 2021 | 9 | August 2022 |
| SPAR (Rectal cancer) | 95 | 222 | 13 April 2018 | 14 | December 2022 |
| SSGXXII (Colorectal Cancer) | 2 | 25-30 | 17 February 2022 | 6 | September 2022 |